Patent · US Active

RSV antiviral pyrazolo- and triazolo-pyrimidine compounds

US10611769B2 · kind B2 · utility

5Cited by

15References

16Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

David Francis Alain Lançois · Louviers, FR
Jérôme Emile Georges Guillemont · Andé, FR
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Dirk André Emmy Roymans · Turnhout, BE
Boris Rogovoy · San Diego, US
Vadim Bichko · San Diego, US
Delphine Yvonne Raymonde Lardeau · Issy-les-Moulineaux, FR
Antoine Benjamin Michaut · Illkirch-Graffenstaden, FR
Anil Koul · Edegem, BE

Key dates

Filing date	Feb 11, 2019
Grant date	Apr 7, 2020
Priority date	—
Expiry date	Feb 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns novel substituted pyrazolo- and triazolo-pyrimidine compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.